Skip to content

South African Nuclear Energy Corporation

South Africa's state-owned nuclear organization for nuclear research, technology development, radioactive-material management, and related commercial activities.

Last updated October 14, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

The South African Nuclear Energy Corporation, commonly known as Necsa, is a South African state-owned public company responsible for nuclear research, development, technology support, and the management of nuclear and other restricted materials. It was established in 1999 under the Republic of South Africa Nuclear Energy Act, replacing the former Atomic Energy Corporation. The organization is wholly owned by the South African state and operates as both a public nuclear institution and a commercial group with activities extending into medical radioisotopes, fluorochemicals, radioactive-waste management, and nuclear-related services. Necsa's institutional history reaches back to the creation of the Atomic Energy Board in 1948. South Africa subsequently developed a broader nuclear infrastructure, including cooperation with the United States to obtain a research reactor in 1957 and the formation of the Uranium Enrichment Corporation in 1970. The Nuclear Energy Act of 1982 created the Atomic Energy Corporation, or AEC, consolidating responsibility for the country's nuclear activities. In 1985, the Uranium Enrichment Corporation and Nuclear Development Corporation were reincorporated into the AEC. The AEC became Necsa in 1999 as South Africa reorganized its nuclear institutions and commercial priorities. The corporation's principal site is at Pelindaba, near Pretoria, where it conducts research and operates nuclear facilities. It also operates the Vaalputs radioactive-waste disposal facility. Necsa's statutory functions include undertaking and promoting research and development in nuclear energy and associated technologies, processing and storing nuclear and other restricted materials, and coordinating with public and private organizations on matters within its mandate. Its work spans nuclear physics, engineering, chemistry, electronics, isotope production, radiation-related technologies, and nuclear-liability management. The SAFARI-1 research reactor is central to Necsa's commercial and scientific activities. Commissioned in 1965 as a 20-megawatt reactor, SAFARI-1 was initially used for high-level nuclear physics research. During the 1970s and 1980s, international restrictions on fuel supply encouraged South Africa to develop domestic capabilities in uranium conversion, enrichment, and nuclear-fuel production. After the country's international reorientation in the 1990s, the organization shifted toward commercially driven projects and expanded the reactor's role in isotope production. Since 2009, SAFARI-1 has operated solely with low-enriched uranium fuel. Its output includes molybdenum-99 and other medical isotopes used in diagnostic imaging and cancer treatment, with international distribution handled through Necsa's radioisotope business. Necsa's group structure includes NTP Radioisotopes SOC, incorporated as a wholly owned subsidiary in 2003, and Pelchem SOC, which became wholly owned in 2007. NTP supplies radiation-based products and services, particularly medical radioisotopes, to domestic and international markets. Pelchem produces fluorochemicals and related chemical products for industrial and household applications. Through these subsidiaries and its core nuclear facilities, Necsa combines public-sector nuclear responsibilities with revenue-generating technology and manufacturing operations. The organization has also remained involved in South Africa's longer-term nuclear strategy. In 2021, the South African cabinet approved a multipurpose reactor project intended to replace SAFARI-1. The proposal reflects the need to preserve isotope-production capacity and research capability as the existing reactor ages. Necsa's current institutional role therefore covers both continuity of established nuclear services and development of replacement infrastructure. Its governance is overseen by a board appointed through the South African government, while executive management is responsible for operating the group, maintaining nuclear safety and security, and supporting commercial and public-interest objectives.

History

South Africa's nuclear institutional history began with the establishment of the Atomic Energy Board in 1948. The board coordinated the country's early atomic-energy activities and later supported international cooperation, including a 1957 agreement with the United States to procure a research reactor. The resulting infrastructure helped establish South Africa's long-term nuclear research base. In 1970, South Africa created the Uranium Enrichment Corporation, reflecting a strategic effort to develop domestic capabilities across the nuclear fuel cycle. The Nuclear Energy Act of 1982 created the Atomic Energy Corporation, known as the AEC, and assigned it responsibility for the country's nuclear-related activities. Two organizations formed in the same period, the Uranium Enrichment Corporation and the Nuclear Development Corporation, were reincorporated into the AEC in 1985. This consolidation gave the AEC a broad mandate covering research, fuel-cycle technology, nuclear materials, and associated industrial activity. The 20-megawatt SAFARI-1 research reactor was commissioned at Pelindaba on 18 March 1965. It initially supported advanced nuclear-physics research. During the 1970s and 1980s, international restrictions on nuclear-fuel supply reduced access to imported fuel and encouraged South Africa to develop domestic technical capacity. Activities at Pelindaba consequently expanded to include uranium conversion to uranium hexafluoride, uranium enrichment, and nuclear-fuel-assembly production. These capabilities formed part of a wider state nuclear program during the apartheid era. Following South Africa's return to wider international engagement in the 1990s, the country's nuclear organization moved toward commercial operations and a changed strategic orientation. The AEC was transformed into the South African Nuclear Energy Corporation in 1999 under the Republic of South Africa Nuclear Energy Act. Necsa became a public company wholly owned by the state, with responsibilities extending beyond research to nuclear-material management, technology development, and support for public nuclear institutions. During the following decade, Necsa developed a group structure around specialized commercial activities. NTP Radioisotopes Group became a wholly owned subsidiary in 2003, and Pelchem became wholly owned in 2007. NTP built an international business supplying radiation-based products, especially medical radioisotopes used in diagnosis and cancer treatment. Pelchem operated in fluorochemicals and related industrial and household applications. SAFARI-1 became the foundation of the isotope-production program, while Necsa also retained responsibilities for nuclear research, technical services, and radioactive-waste management. Since 2009, SAFARI-1 has operated exclusively on low-enriched uranium fuel. This change represented an important adjustment in the reactor's operating model and helped align its continued use with international non-proliferation expectations. Necsa also operates the Vaalputs radioactive-waste disposal facility and carries out other functions connected with nuclear liabilities and restricted materials. In the 2020s, governance continuity and replacement infrastructure became prominent issues. David Nicholls chaired the Necsa Group board from January 2020 and was reappointed in January 2023. Loyiso Tyabashe became chief executive officer on 1 January 2021. In the same year, the South African cabinet approved a multipurpose reactor intended to replace SAFARI-1. The proposed reactor is linked to the continuity of nuclear research and isotope production as the older facility approaches the limits of its long service life. Necsa therefore remains both a national nuclear institution and a group of specialized commercial operations serving South African and international users.

  • 2021

    Multipurpose reactor approved

    [1]

    The South African cabinet approved a multipurpose reactor intended to replace SAFARI-1.

  • 2009

    SAFARI-1 adopts low-enriched uranium fuel

    [1]

    SAFARI-1 began operating solely on low-enriched uranium fuel.

  • 2007

    Pelchem becomes wholly owned

    [1]

    Pelchem became a wholly owned Necsa subsidiary producing fluorochemicals and related products.

  • 2003

    NTP Radioisotopes incorporated as a subsidiary

    [1]

    NTP Radioisotopes Group became a wholly owned Necsa subsidiary focused on radioisotopes and radiation-based products.

  • 1999

    Necsa established

    [1]

    The Atomic Energy Corporation was reorganized as the South African Nuclear Energy Corporation under the Republic of South Africa Nuclear Energy Act.

  • 1985

    Nuclear organizations consolidated into the AEC

    [1]

    The Uranium Enrichment Corporation and Nuclear Development Corporation were reincorporated into the Atomic Energy Corporation.

  • 1982

    Atomic Energy Corporation created

    [1]

    The Nuclear Energy Act of 1982 created the Atomic Energy Corporation, replacing the Atomic Energy Board and consolidating responsibility for nuclear activities.

  • 1970

    Uranium Enrichment Corporation established

    [1]

    South Africa formed the Uranium Enrichment Corporation as part of its effort to develop domestic nuclear-fuel-cycle capabilities.

  • 1965

    SAFARI-1 commissioned

    [1]

    The 20-megawatt SAFARI-1 research reactor was commissioned at Pelindaba on 18 March.

  • 1957

    Research-reactor cooperation agreement

    [1]

    South Africa and the United States signed an agreement to procure a research reactor, strengthening South Africa's nuclear research infrastructure.

Products and positioning

A state-owned nuclear science and technology group combining national nuclear-institutional responsibilities with commercial isotope production, chemical manufacturing, research, and related technical services.

  • Research reactor · 1965

    SAFARI-1

    SAFARI-1 is a 20-megawatt research reactor at Necsa's Pelindaba site. Commissioned in 1965, it began as a facility for nuclear-physics research and later became the cornerstone of South Africa's commercial medical-isotope program. Its irradiation capabilities support the production of radioisotopes, including molybdenum-99, used in medical diagnostic procedures. Since 2009, the reactor has operated exclusively with low-enriched uranium fuel.

  • Nuclear medicine products

    Medical radioisotopes

    Necsa's isotope activities, commercialized internationally through NTP Radioisotopes SOC, include radioisotopes used for medical diagnosis and cancer treatment. SAFARI-1 provides the reactor irradiation base for products such as molybdenum-99. The business serves South African and international markets and connects Necsa's public nuclear-research infrastructure with global healthcare supply chains.

  • Industrial and household chemicals · 2007

    Fluorochemicals

    Pelchem SOC, a wholly owned Necsa subsidiary, produces fluorochemicals and associated chemical products for industrial and household applications. The business represents Necsa's diversification beyond reactor operations and nuclear research into specialized chemical manufacturing based at the group's Pelindaba operations.

  • Nuclear waste management

    Radioactive-waste disposal

    Necsa operates the Vaalputs radioactive-waste disposal facility and undertakes related nuclear-liability and restricted-material functions. These activities support the safe handling, storage, and disposal of radioactive materials generated by nuclear research, industrial uses, and other nuclear operations.

Brand decisions

  • 2021

    Develop a multipurpose reactor to replace SAFARI-1Generation change

    Background

    SAFARI-1 is a long-serving research reactor supporting both scientific work and commercial isotope production. Continued national capability requires a successor facility.

    Action taken

    The South African cabinet approved a multipurpose reactor intended to replace SAFARI-1.

    Aftermath

    The approval established a policy basis for developing replacement research and isotope-production infrastructure, although the supplied reference does not provide a completion date or project cost.

  • 2009

    Transition SAFARI-1 to low-enriched uranium fuelStrategy

    Background

    SAFARI-1 had historically operated within a nuclear environment in which fuel supply and enrichment capability were strategic issues. South Africa's international reorientation increased the importance of operating the reactor with low-enriched fuel.

    Action taken

    SAFARI-1 began operating solely on low-enriched uranium fuel.

    Aftermath

    The reactor continued supporting research and medical-isotope production under a fuel regime more consistent with international non-proliferation objectives.

Recent events

  • 2023

    David Nicholls reappointed as Necsa board chair[1]

    Leadership change

    The Minister of Mineral Resources and Energy reappointed David Nicholls as chair of the Necsa Group board, continuing the governance leadership that began in 2020.

  • 2021

    South African cabinet approves multipurpose reactor concept[1]

    Product generation

    The South African cabinet approved a multipurpose reactor intended to replace the SAFARI-1 research reactor and preserve national research and isotope-production capability.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/south-african-nuclear-energy-corporation · Editorial policy · How profiles are compiled